Acceleron Pharma Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
21,898.00
51,259.00
63,894.00
57,014.00
108,454.00
118,871
Depreciation, Depletion & Amortization
915.00
1,118.00
1,176.00
1,676.00
2,825.00
3,747
Other Funds
-
-
-
-
226.00
24,978
Funds from Operations
8,809.00
50,875.00
47,487.00
44,051.00
76,213.00
90,146
Changes in Working Capital
28,459.00
2,345.00
3,276.00
494.00
331.00
4,560
Net Operating Cash Flow
19,650.00
53,220.00
44,211.00
44,545.00
76,544.00
94,706
Capital Expenditures
307.00
514.00
959.00
3,380.00
4,396.00
Purchase/Sale of Investments
-
-
108,012.00
105,425.00
59,970.00
Net Investing Cash Flow
307.00
514.00
108,971.00
108,805.00
64,366.00
Issuance/Reduction of Debt, Net
3,669.00
16,331.00
-
-
-
Net Financing Cash Flow
93,509.00
117,031.00
4,505.00
146,667.00
220,296.00
Net Change in Cash
73,552.00
63,297.00
148,677.00
6,683.00
79,386.00
Free Cash Flow
19,957.00
53,734.00
45,170.00
47,925.00
80,940.00
Change in Capital Stock
97,178.00
133,362.00
4,505.00
146,667.00
220,522.00
About Acceleron Pharma
View Profile
